MICHIGAN STATE UNIVERSITY
Leveraging modulation of polyamine metabolism for therapeutic advantage in genetic disorders
Leveraging modulation of polyamine metabolism for therapeutic advantage in genetic disorders is a funding opportunity from MICHIGAN STATE UNIVERSITY, up to 661116, closing January 31, 2028.
Jan 31, 2028
(549d left)Overview
ABSTRACT We are at the forefront of investigating novel neurodevelopmental disorders associated with polyamines. Our overarching hypothesis is that mutations in genes of the polyamine pathway result in pathologically unbalanced polyamine profiles in affected individuals that lead to neurodevelopmental disorders.…